Bicara Therapeutics Inc. ... (BCAX)
11.83
-1.43 (-10.78%)
At close: Apr 03, 2025, 3:59 PM
11.69
-1.18%
Pre-market: Apr 04, 2025, 04:26 AM EDT
Bicara Therapeutics Common Stock Revenue
Bicara Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2024, Bicara Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
55
Market Cap
645.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |